首页> 外文OA文献 >Amélioration des résultats de la thérapie cellulaire hépatique : Développement d’une nouvelle méthode de préparation du foie receveur et développement d’une source cellulaire alternative aux hépatocytes
【2h】

Amélioration des résultats de la thérapie cellulaire hépatique : Développement d’une nouvelle méthode de préparation du foie receveur et développement d’une source cellulaire alternative aux hépatocytes

机译:改善肝细胞治疗的结果:开发一种制备受体肝脏的新方法以及开发一种替代肝细胞的细胞来源

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Hepatocyte transplantation has been proposed as an alternative to orthotopic liver transplantation to treat metabolic liver diseases. This approach requires preconditioning of the host liver to enhance engraftment of transplanted hepatocytes. Different methods are currently used in preclinical models: partial hepatectomy, portal ligature or embolization, and radiotherapy or chemotherapeutic drugs. However, these methods carry high risks of complications and are problematic for use in clinical practice. Here, we developed an innovative method called volumetric (distal, partial and random) portal embolization (EPV), which preserves total liver volume.METHODS: Embolization was performed in the portal trunk of C57BL6 adult mice with polyester microspheres, to ensure a bilateral and distal distribution. The repartition of microspheres was studied by angiographic and histological analysis. Liver regeneration was evaluated by Ki67 labeling. Optimal conditions for EPV were determined and the resulting regeneration was compared with that following partial hepatectomy (70%). Labeled adult hepatocytes were then transplanted and engraftment was compared between embolized (n=19) and non embolized mice (n=8). Engraftment was assessed in vivo and histologically by tracking labeled cells at day 5. RESULTS: The best volumetric embolization conditions, which resulted in the regeneration of 5% of total liver, were 8x106 10µm microspheres infused with a 29 G needle directly into the portal trunk at 3.3ml/s. In these conditions, transplanted hepatocytes engraftment was significantly higher than in control conditions (3 vs 0.65%). CONCLUSIONS: EPV is a new, minimally invasive and efficient technique to prepare the host liver for cell transplantation.
机译:已经提出肝细胞移植可以替代原位肝移植来治疗代谢性肝病。这种方法需要对宿主肝脏进行预处理,以增强移植肝细胞的植入。目前在临床前模型中使用了不同的方法:部分肝切除术,门脉结扎术或栓塞术以及放疗或化疗药物。但是,这些方法存在并发症的高风险,并且在临床实践中存在问题。在这里,我们开发了一种创新的方法,称为容积(远侧,部分和随机)门静脉栓塞(EPV),可以保留总肝脏体积。远端分布。通过血管造影和组织学分析研究了微球的重新分配。通过Ki67标记评估肝脏再生。确定了EPV的最佳条件,并将所产生的再生与部分肝切除术后的再生进行了比较(70%)。然后移植标记的成年肝细胞,比较栓塞(n = 19)和非栓塞小鼠(n = 8)的植入情况。在第5天通过跟踪标记的细胞在体内和组织学上评估移植的结果。结果:最佳的体积栓塞条件是8x106 10µm微球,用29 G针直接注入门静脉,可导致总肝脏再生5%。速度为3.3毫升/秒。在这些条件下,移植肝细胞的植入显着高于对照条件(3比0.65%)。结论:EPV是一种新的,微创且有效的技术,可为细胞移植准备宿主肝脏。

著录项

  • 作者

    Pourcher Guillaume;

  • 作者单位
  • 年度 2015
  • 总页数
  • 原文格式 PDF
  • 正文语种 fr
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号